Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07789041
NA
Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge
Sponsor: Endeavor Health
View on ClinicalTrials.gov
Summary
Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure
Official title: PuraStat for Aquablation Day Case (Use of PuraStat Following an Aquablation Procedure)
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-08-12
Completion Date
2026-12-12
Last Updated
2026-08-27
Healthy Volunteers
No
Interventions
DEVICE
PuraStat hydrogel and the syringe
PuraStat device is FDA-approved for other uses, such as gastrointestinal endoscopy and ENT (ear, nose, throat) procedures. Its use in this study for urology is investigational.
Locations (1)
Glenbrook Hospital- Endeavor Health
Glenview, Illinois, United States